211 filings
Page 7 of 11
8-K
x7c5hiuz
6 Feb 19
Corvus Presents Updated Biomarker and Clinical Results from Lead Pipeline Programs CPI-444 and CPI-006 at Immuno-Oncology 360° Conference
8:35am
8-K
f14v3b69rvz04
28 Jan 19
Corvus Pharmaceuticals Announces Appointment of New Member of Board of Directors and Hiring of Chief Medical Officer
4:10pm
8-K
fhhth sogxc9cf5v
10 Jan 19
Corvus Announces Presentation of Preclinical Data on CPI-818, a First-in-class Covalent Inhibitor of ITK Targeting T-Cell Lymphomas
8:35am
8-K
iabs9w0rj1ff 0ik
8 Jan 19
Regulation FD Disclosure
8:30am
8-K
bdo3aznvny
14 Dec 18
Departure of Directors or Certain Officers
4:15pm
8-K
ietw niq1pminokce
13 Nov 18
Corvus Pharmaceuticals Announces Updated Results from Ongoing Clinical Studies of Lead Programs, CPI-444 and CPI-006, at SITC 33rd Annual Meeting
8:30am
8-K
n7xip4dhdfhvty 7v5q
1 Nov 18
Corvus Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
4:15pm
8-K
q04fupqr
22 Oct 18
Regulation FD Disclosure
8:35am
8-K
m5ipgo 0htknoyn1pr7
3 Oct 18
Regulation FD Disclosure
4:15pm
UPLOAD
bzec6ike ip7wrfp0
24 Aug 18
Letter from SEC
12:00am
CORRESP
meb2hl k4tckpd
17 Aug 18
Correspondence with SEC
12:00am
8-K
dvryzefvn11sraygfcfn
2 Aug 18
Corvus Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
4:20pm
UPLOAD
0leskr3z1s3q ygy
1 Aug 18
Letter from SEC
12:00am
8-K
3fps31z 9n
28 Jun 18
Regulation FD Disclosure
8:35am
8-K
gswym6i6hme
22 Jun 18
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
jhasmb
3 May 18
Corvus Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
4:11pm